The Digital Health & AI Tools in Neuroscience market is projected to grow significantly, reaching $79.30 billion by 2033, up from $31.25 billion in 2024, at a CAGR of 9.9% from 2025-2033. A recent report by DataM Intelligence highlights key growth drivers, such as the prevalence of neurological disorders affecting 3.4 billion people globally and a pressing need for scalable AI solutions in mental health. North America dominates the market with 43.5% revenue in 2024, while Asia-Pacific shows rapid growth at 8.1% CAGR. Software is the leading segment, accounting for 45.1% of the market, driven by advancements like AI neurodiagnostics and brain-computer interfaces. Major players include Akili Interactive, Neuralink, and Biofourmis. The report also outlines challenges such as high costs hindering scalability, yet emphasizes opportunities for businesses to innovate and invest in this evolving landscape.
Source link
Share
Read more